Natera outlines $2.62B-$2.7B 2026 revenue target amid record MRD growth and margin expansion
Source: SeekingAlpha
2026-02-26 21:38:37 ET
More on Natera
- Natera, Inc. (NTRA) Q4 2025 Earnings Call Transcript
- Natera, Inc. (NTRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Natera, Inc. (NTRA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Natera reports Q4 results
- Natera Q4 2025 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Natera outlines $2.62B-$2.7B 2026 revenue target amid record MRD growth and margin expansion
Natera Inc.
NASDAQ: NTRA
NTRA Trading
0.56% G/L:
$202.56 Last:
291,044 Volume:
$205.98 Open:
NTRA Latest News
February 28, 2026 04:57:00 am
3 Reasons Exelixis Stock Could Deliver Market?Beating Returns Over the Next Decade
February 27, 2026 10:05:00 am
Signatera(TM) MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation
NTRA Stock Data
$29,241,088,573
130,533,658
0.75%
312
N/A
Medical Diagnostics & Screening
Healthcare
US
Austin
